Evidence map›Paper›PMID 28884202›Full record

ArticleDiabetologia2017

Gcg

Chiyo Shiota, Krishna Prasadan, Ping Guo, Joseph Fusco, Xiangwei Xiao, George K Gittes

Open access · bronzeAbstract read
In one paragraph

Article in Diabetologia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 43 citations in OpenAlex.

  1. mNature metabolism · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Role of complexin 2 in the regulation of hormone secretion from the islet of Langerhans.American journal of physiology. Endocrinology and metabolism · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Chiyo ShiotaDivision of Pediatric Surgery, Department of Surgery, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, 4401 Penn Ave, Pittsburgh, PA, 15224, USA. chiyo.shiota@vanderbilt.edu.
Krishna PrasadanDivision of Pediatric Surgery, Department of Surgery, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, 4401 Penn Ave, Pittsburgh, PA, 15224, USA.
Ping GuoDivision of Pediatric Surgery, Department of Surgery, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, 4401 Penn Ave, Pittsburgh, PA, 15224, USA.
Joseph FuscoDivision of Pediatric Surgery, Department of Surgery, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, 4401 Penn Ave, Pittsburgh, PA, 15224, USA.
Xiangwei XiaoDivision of Pediatric Surgery, Department of Surgery, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, 4401 Penn Ave, Pittsburgh, PA, 15224, USA.
George K GittesDivision of Pediatric Surgery, Department of Surgery, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, 4401 Penn Ave, Pittsburgh, PA, 15224, USA. gittesgk@upmc.edu.
Children's Hospital of Pittsburgh · USUniversity of Pittsburgh · US

Funding

Endogenous alpha-to-beta cell transdifferentiation in diabetesR01DK112836 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GITTES, GEORGE K. · 2017 to 2020
$1.5M
EGF and TGF-β signaling synergy in β-cell proliferationR01DK111460 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GITTES, GEORGE K. · 2016 to 2018
$1.2M
Pancreatic Intra-Islet DuctsR01DK098196 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GITTES, GEORGE K. · 2013 to 2014
$667k
NIDDK NIH HHS R01 DK098196NIDDK NIH HHS R01 DK111460NIDDK NIH HHS R01 DK112836
6 · The paper itself

Abstract

aims/hypothesisThe Cre/loxP system, which enables tissue-specific manipulation of genes, is widely used in mice for diabetes research. Our aim was to develop a new Cre-driver mouse line for the specific and efficient manipulation of genes in pancreatic alpha cells.

methodsA Gcg

resultsTamoxifen-treated Gcg CONCLUSIONS/

interpretationThe newly developed Gcg

Indexed as

AnimalsFemaleGlucagonGlucagon-Like Peptide 1Glucagon-Secreting CellsImmunohistochemistryMaleMiceMice, TransgenicProglucagonTamoxifenGlucagonGlucagon-Like Peptide 1ProglucagonTamoxifenCreERT2Cre/loxPPancreatic alpha cellsProglucagon

Identifiers

PMID28884202
PMCPMC5671347
OpenAlexW2751055686

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.